179 related articles for article (PubMed ID: 10340918)
1. The cytotoxicity of clozapine metabolites: implications for predicting clozapine-induced agranulocytosis.
Tschen AC; Rieder MJ; Oyewumi LK; Freeman DJ
Clin Pharmacol Ther; 1999 May; 65(5):526-32. PubMed ID: 10340918
[TBL] [Abstract][Full Text] [Related]
2. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man.
Maggs JL; Williams D; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1463-75. PubMed ID: 8531117
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis.
Williams DP; Pirmohamed M; Naisbitt DJ; Maggs JL; Park BK
J Pharmacol Exp Ther; 1997 Dec; 283(3):1375-82. PubMed ID: 9400013
[TBL] [Abstract][Full Text] [Related]
4. Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: a potential in vitro system for the study of agranulocytosis.
Pereira A; Dean B
Biochem Pharmacol; 2006 Sep; 72(6):783-93. PubMed ID: 16844094
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity in serum of patients with clozapine-induced agranulocytosis.
Pisciotta AV; Konings SA; Ciesemier LL; Cronkite CE; Lieberman JA
J Lab Clin Med; 1992 Mar; 119(3):254-66. PubMed ID: 1541875
[TBL] [Abstract][Full Text] [Related]
6. Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis.
Iverson S; Zahid N; Uetrecht JP
Chem Biol Interact; 2002 Nov; 142(1-2):175-99. PubMed ID: 12399162
[TBL] [Abstract][Full Text] [Related]
7. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis.
Fischer V; Haar JA; Greiner L; Lloyd RV; Mason RP
Mol Pharmacol; 1991 Nov; 40(5):846-53. PubMed ID: 1658615
[TBL] [Abstract][Full Text] [Related]
8. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
9. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
10. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
Alfaro J; Berdichevsky E; Conte G; Tellez C
Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
[TBL] [Abstract][Full Text] [Related]
11. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
12. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
Güzelcan Y; Scholte WF
Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
[TBL] [Abstract][Full Text] [Related]
13. Increased apoptosis of neutrophils in a case of clozapine-induced agranulocytosis - a case report.
Loeffler S; Fehsel K; Henning U; Fischer J; Agelink M; Kolb-Bachofen V; Klimke A
Pharmacopsychiatry; 2003 Jan; 36(1):37-41. PubMed ID: 12649775
[TBL] [Abstract][Full Text] [Related]
14. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
15. Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.
Dettling M; Sachse C; Müller-Oerlinghausen B; Roots I; Brockmöller J; Rolfs A; Cascorbi I
Pharmacopsychiatry; 2000 Nov; 33(6):218-20. PubMed ID: 11147929
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
17. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
18. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced agranulocytosis in a Native American: HLA typing and further support for an immune-mediated mechanism.
Pfister GM; Hanson DR; Roerig JL; Landbloom R; Popkin MK
J Clin Psychiatry; 1992 Jul; 53(7):242-4. PubMed ID: 1639743
[TBL] [Abstract][Full Text] [Related]
20. Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis.
Lobach AR; Uetrecht J
Chem Res Toxicol; 2014 Apr; 27(4):699-709. PubMed ID: 24588327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
